The present invention relates generally to phenylglycinamide derivatives that inhibit serine proteases. In particular it0 is directed to novel phenylglycinamide derivatives, and analogues thereof, which are useful as selective inhibitors of serine protease enzymes of the coagulation cascade; for example thrombin, factor VIIa, factor Xa, factor XIa, factor IXa, and/or plasma kallikrein. In particular, it relates to compounds that are factor VIIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of using the same.

 
Web www.patentalert.com

< Cationic hydrophilic siloxanyl monomers

> Process for identifying a ligand that binds to the NEP binding site for the SMR1 pentapeptide

> Treatment of patients with dysfunctional cardiac sodium channels

~ 00564